Lucía Cabal‐Hierro

1.0k total citations
16 papers, 796 citations indexed

About

Lucía Cabal‐Hierro is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Lucía Cabal‐Hierro has authored 16 papers receiving a total of 796 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Cancer Research and 4 papers in Oncology. Recurrent topics in Lucía Cabal‐Hierro's work include Cell death mechanisms and regulation (5 papers), NF-κB Signaling Pathways (5 papers) and Acute Myeloid Leukemia Research (2 papers). Lucía Cabal‐Hierro is often cited by papers focused on Cell death mechanisms and regulation (5 papers), NF-κB Signaling Pathways (5 papers) and Acute Myeloid Leukemia Research (2 papers). Lucía Cabal‐Hierro collaborates with scholars based in United States, Spain and France. Lucía Cabal‐Hierro's co-authors include Pedro S. Lazo, Montserrat A. de la Rosa Rodriguez, Miguel A. Prado, Andrew A. Lane, Peter J. O’Dwyer, Katsuhiro Togami, Bryant G. Darnay, Richard M. Stone, Naveen Pemmaraju and Gabriel K. Griffin and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Blood.

In The Last Decade

Lucía Cabal‐Hierro

15 papers receiving 788 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lucía Cabal‐Hierro United States 10 316 270 172 130 107 16 796
Mika Nishihara Japan 7 292 0.9× 522 1.9× 246 1.4× 62 0.5× 61 0.6× 9 996
Lingxiao Xu China 19 313 1.0× 283 1.0× 177 1.0× 82 0.6× 102 1.0× 49 843
Kouji Matsushima Japan 16 333 1.1× 447 1.7× 282 1.6× 200 1.5× 143 1.3× 21 1.1k
Rita Bisogni Italy 14 502 1.6× 239 0.9× 192 1.1× 167 1.3× 69 0.6× 25 868
Esther P.M. Tjin Netherlands 19 497 1.6× 461 1.7× 284 1.7× 52 0.4× 77 0.7× 33 1.2k
Robert Ortmann United States 15 191 0.6× 355 1.3× 196 1.1× 45 0.3× 104 1.0× 21 873
María Ángeles García-López Spain 13 254 0.8× 546 2.0× 233 1.4× 66 0.5× 64 0.6× 20 1.0k
Jason Douangpanya United States 5 357 1.1× 437 1.6× 131 0.8× 29 0.2× 52 0.5× 5 784
Bing Wu China 14 285 0.9× 400 1.5× 155 0.9× 106 0.8× 112 1.0× 59 861
Teresina Laragione United States 17 495 1.6× 385 1.4× 216 1.3× 109 0.8× 71 0.7× 45 1.0k

Countries citing papers authored by Lucía Cabal‐Hierro

Since Specialization
Citations

This map shows the geographic impact of Lucía Cabal‐Hierro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lucía Cabal‐Hierro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lucía Cabal‐Hierro more than expected).

Fields of papers citing papers by Lucía Cabal‐Hierro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lucía Cabal‐Hierro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lucía Cabal‐Hierro. The network helps show where Lucía Cabal‐Hierro may publish in the future.

Co-authorship network of co-authors of Lucía Cabal‐Hierro

This figure shows the co-authorship network connecting the top 25 collaborators of Lucía Cabal‐Hierro. A scholar is included among the top collaborators of Lucía Cabal‐Hierro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lucía Cabal‐Hierro. Lucía Cabal‐Hierro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Obispo, Berta, Caroline Bailleux, Blanca Cantos, et al.. (2025). Long-Term Adverse Events Following Early Breast Cancer Treatment with a Focus on the BRCA-Mutated Population. Cancers. 17(15). 2506–2506.
2.
Larrainzar‐Garijo, Ricardo, Judith Marín‐Corral, David Casadevall, et al.. (2024). Predictive model for a second hip fracture occurrence using natural language processing and machine learning on electronic health records. Scientific Reports. 14(1). 532–532. 3 indexed citations
3.
Yang, Jing, Ellen Weisberg, Xiaoxi Liu, et al.. (2021). Small molecule inhibition of deubiquitinating enzyme JOSD1 as a novel targeted therapy for leukemias with mutant JAK2. Leukemia. 36(1). 210–220. 19 indexed citations
4.
Cabal‐Hierro, Lucía, Peter van Galen, Miguel A. Prado, et al.. (2020). Chromatin accessibility promotes hematopoietic and leukemia stem cell activity. Nature Communications. 11(1). 1406–1406. 39 indexed citations
5.
Mowery, Cody T., Jaime M. Reyes, Lucía Cabal‐Hierro, et al.. (2018). Trisomy of a Down Syndrome Critical Region Globally Amplifies Transcription via HMGN1 Overexpression. Cell Reports. 25(7). 1898–1911.e5. 42 indexed citations
6.
Cabal‐Hierro, Lucía & Peter J. O’Dwyer. (2017). TNF Signaling through RIP1 Kinase Enhances SN38-Induced Death in Colon Adenocarcinoma. Molecular Cancer Research. 15(4). 395–404. 16 indexed citations
7.
Montero, Joan, Jason Stephansky, Tianyu Cai, et al.. (2016). Blastic Plasmacytoid Dendritic Cell Neoplasm Is Dependent on BCL2 and Sensitive to Venetoclax. Cancer Discovery. 7(2). 156–164. 144 indexed citations
8.
Montero, Joan, Jason Stephansky, Tianyu Cai, et al.. (2016). Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Is Highly BCL-2 Dependent and Sensitive to Venetoclax. Blood. 128(22). 4045–4045. 3 indexed citations
9.
Vasilevskaya, Irina A., et al.. (2015). Inhibition of JNK Sensitizes Hypoxic Colon Cancer Cells to DNA-Damaging Agents. Clinical Cancer Research. 21(18). 4143–4152. 22 indexed citations
10.
Cabal‐Hierro, Lucía, et al.. (2014). TRAF-mediated modulation of NF-kB AND JNK Activation by TNFR2. Cellular Signalling. 26(12). 2658–2666. 57 indexed citations
11.
Cabal‐Hierro, Lucía, Miguel A. Prado, Pedro Casado, et al.. (2013). A TRAF2 binding independent region of TNFR2 is responsible for TRAF2 depletion and enhancement of cytotoxicity driven by TNFR1. Oncotarget. 5(1). 224–236. 23 indexed citations
12.
Cabal‐Hierro, Lucía & Pedro S. Lazo. (2012). Signal transduction by tumor necrosis factor receptors. Cellular Signalling. 24(6). 1297–1305. 353 indexed citations
13.
Rodriguez, Montserrat A. de la Rosa, et al.. (2011). NF-κB Signal Triggering and Termination by Tumor Necrosis Factor Receptor 2. Journal of Biological Chemistry. 286(26). 22814–22824. 55 indexed citations
14.
Fernández‐García, Belén, Pedro Casado, Miguel A. Prado, et al.. (2010). Proteomic Analysis of Annexin A2 Phosphorylation Induced by Microtubule Interfering Agents and Kinesin Spindle Protein Inhibitors. Journal of Proteome Research. 9(9). 4649–4660. 7 indexed citations
15.
Casado, Pedro, Miguel A. Prado, Pedro Zuazua‐Villar, et al.. (2008). Microtubule interfering agents and KSP inhibitors induce the phosphorylation of the nuclear protein p54nrb, an event linked to G2/M arrest. Journal of Proteomics. 71(6). 592–600. 9 indexed citations
16.
Prado, Miguel A., Pedro Casado, Pedro Zuazua‐Villar, et al.. (2007). Phosphorylation of human eukaryotic elongation factor 1Bγ is regulated by paclitaxel. PROTEOMICS. 7(18). 3299–3304. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026